Skip to main content
. 2022 Jan 18;13(2):2878–2888. doi: 10.1080/21655979.2022.2025695

Figure 1.

Figure 1.

Expression of ARHGAP9 was analyzed by GEPIA database. (a) ARHGAP was downregulated in in non-small cell lung cancer patients. (b) The low expression of ARHGAP9 was significantly correlated with the pathological stage of lung adenocarcinoma. (c) The low expression of ARHGAP9 was significantly correlated with the low overall survival rate of lung adenocarcinoma patients. (d) The low expression of ARHGAP9 was significantly correlated with the low disease-free survival rate of lung adenocarcinoma patients. LUAD, lung adenocarcinoma; LUSC, lung squamous cell carcinoma.